{
    "name": "methenamine",
    "comment": "Rx",
    "other_names": [
        "Hiprex",
        "Urex"
    ],
    "classes": [
        "Antibiotics",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/hiprex-methenamine-342580",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: excreted in breast milk; no adverse effects documented"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: excreted in breast milk; no adverse effects documented"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to methenamine or tartrazine (FD&C Yellow No. 5)",
                "Severe renal or hepatic insufficiency",
                "Concurrent sulfonamides or acetazolamide may form insoluble precipitate in urine"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Patients with pre-existing hepatic insufficiency may suffer adverse effects from the small amounts of ammonia and formaldehyde that are produced; the classical syndrome of acute hepatic failure may be evoked in these patients",
                "Taking therapy in absence of proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to patient and increases risk of development of drug-resistant bacteria",
                "Large doses of methenamine (8 g daily for 3 to 4 weeks) have caused bladder irritation, painful and frequent micturition, albuminuria, and gross hematuria",
                "Maintain acidic pH of urine, especially when treating urea-splitting organisms, e.g. Proteus, Pseudomonas",
                "Monitor LFTs, especially in patients with history of liver impairment",
                "Safe use not established during pregnancy, especially 1st and 2nd trimester",
                "May precipitate uric acid stones in patients with gout"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "acetazolamide",
            "description": {
                "common": "acetazolamide, methenamine. Other (see comment). Contraindicated. \nComment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "cholera vaccine",
            "description": {
                "common": "methenamine, cholera vaccine. pharmacodynamic antagonism. Avoid or Use Alternate Drug. Avoid coadministration of cholera vaccine with systemic antibiotics since these agents may be active against the vaccine strain. Do not administer cholera vaccine to patients who have received oral or parenteral antibiotics within 14 days prior to vaccination."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "microbiota oral",
            "description": {
                "common": "methenamine decreases effects of microbiota oral by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Microbiota oral contains bacterial spores. Antibacterial agents may decrease efficacy if coadministered. Complete antibiotic regimens 2-4 days before initiating microbiota oral. ."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sulfadiazine",
            "description": {
                "common": "methenamine, sulfadiazine. Other (see comment). Contraindicated. \nComment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sulfamethoxazole",
            "description": {
                "common": "methenamine, sulfamethoxazole. Other (see comment). Contraindicated. \nComment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sulfisoxazole",
            "description": {
                "common": "methenamine, sulfisoxazole. Other (see comment). Contraindicated. \nComment: This combination may form an insoluble precipitate in the urine, decreasing the effects of both agents."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "pseudoephedrine",
            "description": {
                "common": "methenamine decreases effects of pseudoephedrine by unknown mechanism. Use Caution/Monitor. Urinary excretion of indirect acting alpha/beta agonists (eg, pseudoephedrine) may increase when administered concomitantly with urinary acidifying agents, resulting in lower serum concentrations."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "sodium picosulfate/magnesium oxide/anhydrous citric acid",
            "description": {
                "common": "methenamine decreases effects of sodium picosulfate/magnesium oxide/anhydrous citric acid by altering metabolism. Use Caution/Monitor. Coadministration with antibiotics decreases efficacy by altering colonic bacterial flora needed to convert sodium picosulfate to active drug."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "To report suspected adverse reactions",
            "percent": "1-866"
        },
        {
            "name": "contact Validus Pharmaceuticals LLC at",
            "percent": "982-5438"
        },
        {
            "name": "VALIDUS",
            "percent": "1-866"
        },
        {
            "name": "or FDA at",
            "percent": "9"
        },
        {
            "name": "FDA",
            "percent": "1-800"
        },
        {
            "name": "or www",
            "percent": "1088"
        },
        {
            "name": "fda",
            "percent": null
        },
        {
            "name": "gov",
            "percent": null
        },
        {
            "name": "medwatch",
            "percent": null
        },
        {
            "name": "Dysuria",
            "percent": null
        },
        {
            "name": "Gastric upset",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        }
    ]
}